title: [Radiofrequency thermal ablation combined with arterial embolization for primary liver cancer].
abstract: OBJECTIVE
  To explore the short-term effect of radiofrequency ablation (RFA) combined with arterial embolization in treating patients with primary liver cancer.
  
  
  METHODS
  Thirty patients with primary liver cancer received the combined treatment and the pre- and post-operative alpha-fetoprotein (AFP) levels, imaging features, and liver function were investigated along with observation of the incidence of complications to evaluate the therapeutic effects.
  
  
  RESULTS
  The post-operative AFP positivity and the tumor density were significantly reduced in these patients, and their one-year survival rate reached 96.7% with only minor complications observed.
  
  
  CONCLUSIONS
  RFA combined with arterial embolization is effective for primary liver cancer.
authors.affiliation: Guangzhou Tumor Hospital and Clinical Center for Cancer Research of Guangzhou Medical College, Guangzhou 510095, China.
authors.forename: Shu-zhong
authors.initials: SZ
authors.lastname: Cui
authors.forename: Hai-ying
authors.initials: HY
authors.lastname: Liu
authors.forename: Yun-qiang
authors.initials: YQ
authors.lastname: Tang
authors.forename: Wei-min
authors.initials: WM
authors.lastname: Hu
authors.forename: Jia-kang
authors.initials: JK
authors.lastname: Wang
authors.forename: Jian-chang
authors.initials: JC
authors.lastname: Li
authors.forename: Tao
authors.initials: T
authors.lastname: Song
authors.forename: Sheng-qu
authors.initials: SQ
authors.lastname: Lin
mesh_terms: D000328:Adult; D000368:Aged; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D000509:alpha-Fetoproteins